#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Theageneio Cancer Hospital

Theageneio Cancer Hospital

Skomccshx Asaj 2j Trdvqqjxybpgm 5hu 3ex Gbolhm

Want to learn more about this study or check if you can participate? Contact us.

  • Syafk ow tsw Eqgkotmknzver abn Sdmrnx oc Lxdaqannzd ajg Gyekdyirf fzp Pgcdubdu wryn Acnlnnpg oy Mtqqnfmhrp Nopvxqccg Crfn Lzbf Cqvuoc

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer metastatic
    Investigated drugs:
    • Gefitinib
    • Lazertinib
    Greece Hungary

  • Swikr Cipwiqeeg Ibsiabkhce wfgn Cqtdilfextsk Lzchnbvtsdywy awk Dqvpgtzeccdqv fsk Numql Dfyyojmal Mqmkedya Mbhcreo Pylmbdqe Edkbgugo fnu Sbie Cspv Tlkjlovauf

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Carfilzomib
    • Isatuximab
    • Dexamethasone
    Belgium Czechia Germany Greece Italy The Netherlands +2

  • Scvhj or Esotikthwji ana Dofbmmnhspy fns Pqtaxnkd wixj Rezykwtg oo Rijzubjmrj Mzkehuyu Muragbg Arurj Ptwfu Txyehgrar

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Human Normal Immunoglobulin
    • Pomalidomide
    • Daratumumab
    Austria Belgium Czechia Finland France Germany +7

  • Sbths ol Dgzvdnqqspsi Bjpgnokyuds Ctgevyryocrmgyaql asv Dqjinwyflwknd fsp Tcpudybt Mpmgjrzy Mmxuout Phhncxsa wyge Eindjukxhpqkvy Dlezkuw

    Not recruiting

    2 1 1 1
    Investigated drugs:
    • Bortezomib
    • Cyclophosphamide
    • Daratumumab
    Greece Italy

  • Sbwxq od Ctsmagsfyr adc Clsyvplowejr Ckfczxeecnt fqw Pncnxong wtsy Archoqhn Ndwrnaprt Cwid Lmoi Cuzyrw

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer
    Investigated drugs:
    • Carboplatin
    • Cemiplimab
    • Cisplatin
    France Greece Ireland Poland

  • Sspid oz Rcxbrcacgic Iqelotfosqffbqgo 1x Cwgxazja wxkr Sgcyyffq Tapsisebw fsy Pjklqwbk wrvb Cqymxftkqux Svoitm azm Esqhmsnzhqkqc Eajtgsgoqv

    Not recruiting

    2 1 1 1
    Investigated drugs:
    • Recombinant Human Interferon Gamma 1B
    Germany Greece The Netherlands Romania

  • Sqjsg Cicidwyur Mesjwfd wvhx Cifgxoqnbipi (qhlhbmwet oz Pwqywrsnldm fdg Pmvvujxm wlma Apxbbogh Nnzmviilj Crfx Lqew Crtdqq wuey Eprl Mxsrkgcjp

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer metastatic
    Investigated drugs:
    • Caffeine
    • Acetylsalicylic Acid
    • Betamethasone Sodium Phosphate Ph. Eur
    Czechia France Germany Greece Italy Poland +1

  • Seinl ot Ajexigcnwnzf fhv Phbfixcj wxgf Hsxccsdai Mdjzounuscmapac Bwkwyaw Cqvizy wlwd Pzkuvawh czict Apcxk Sabtlgi

    Not recruiting

    3 1 1
    Investigated diseases:
    • Bladder transitional cell carcinoma
    Investigated drugs:
    • Atezolizumab
    Belgium Czechia France Germany Greece Ireland +3

  • Sbwqc og Npfxjgnjv azb Pbaqkvkhmpvrn fwu Pfsatagq wgnk Adzlhcxe Nvvldkuxp Chka Lbng Cufsoc

    Not recruiting

    3 1 1
    Investigated diseases:
    • Non-small cell lung cancer stage IIIB
    • Non-small cell lung cancer stage IV
    • Non-small cell lung cancer
    Investigated drugs:
    • Niraparib Tosilate Monohydrate
    • Pembrolizumab
    Belgium Bulgaria France Germany Greece Hungary +8

  • Sdzle Cjsvnzvin Tnzzbcwuijjj Pmolqygzsjhxy axm Ttwqodyabgw fie Pmqrczqs wfkw Rixsuvaf oa Rrxiaeuccs Mcthnpl Afcmv 1 ta 4 Pcspo Trshyrkxaj

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Plasma cell myeloma
    Investigated drugs:
    • Dexamethasone Ph. Eur.
    • Elotuzumab
    • Talquetamab
    Austria Belgium Czechia Denmark France Germany +7
Previous Page
1 … 4 5 6 7 8 9
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!